Page 216 - Development Group News Today

What’s the latest with plans for 1,570-home Reveille subdivision in South Hall? A South Hall project known as Reveille will include 122,500 square feet of retail space, 122,500 square feet of office space, 560 apartments, 75 townhomes, 25, assisted-living townhomes and a 175-room hotel. A Southern coastal craftsman type architectural theme would be used throughout the development. No dirt has been turned on the property, but Reveille, a 509-acre mixed-u...

UCLA March 4, 2021 Seventeen researchers at UCLA have been named recipients of awards from the 2020 UCLA Innovation Fund Biomedical Competition. These awards, up to $200,000 per project, support early stage research that lead to commercialization activities, which usually aren’t supported by basic research grants. As a result, researchers can develop their technologies to a point where the chances of success are greatly increased. Importantly, all awarded projects receive consultations from a...

/PRNewswire/ -- NEXS Research & Development Group is proud to announce a major advancement in its efforts to protect frontline medical, research, and...

UCLA MedTech/Courtesy of vfairs.com March 3, 2021 WHAT The UCLA Technology Development Group is hosting the ninth annual MedTech Partnering Conference. The event is dedicated to providing unique opportunities for inventors, researchers, scientists and medical and technology industry executives to establish relationships that will help further innovations in the fields of medicine, research and technology.  The 2021 gathering will be the first-ever virtual conference in the event’s history. T...

Litigation Release No. 25041 / March 2, 2021 Securities and Exchange Commission v. Renew Forestry Group, LLC et al., No. 1:21-cv-00081-SPB (W.D. Pa. filed March 1, 2021) The Securities and Exchange Commission charged Pennsylvania resident Brian A. Miller with fraudulently offering and selling at least $1.1 million of securities to approximately 36 investors through Millers companies, Renew Forestry Group, LLC, Renew Development Group, LLLP, and Renew Holdings, LLC between February 2016 and Augu...

The drug hydroxychloroquine, once touted by Donald Trump as a pandemic “game-changer”, should not be used to prevent Covid-19 and has no meaningful effect on patients already infected, a World Health Organisation expert panel said on Tuesday. The anti-inflammatory drug should not be used in the fight against the pandemic, the WHO’s Guideline Development Group (GDG) expert panel wrote in...

Expert panel says the medicine has no meaningful effects on patients

The recommendation comes from a WHO Guideline Development Group, which are a panel of international experts.

The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in

Mike Rundle / WCBU Upon their first introduction to Sankoty Lakes Resort, residents of Spring Bay may have felt that it was a gift from heaven. “I belong to the Methodist church here in town, so I had the pastor get everybody together and I preached a Sunday sermon,” said Kim Blickenstaff, chairman and founder of KDB Development Group, the enterprise behind the resort. “They generally get 80 to 100 people every Sunday, and they got over 200, so that was how we informed the community bec...